Robert A. Fowler
Impact in
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Inflammatory mediators and NSAID effects 3
- Co-authors
- Scott David Solomon (3 shared papers)Janet Turk Wittes (3 shared papers)Ann Graham Zauber (2 shared papers)Peter V. Finn (2 shared papers)Monica M. Bertagnolli (2 shared papers)Ernest T. Hawk (2 shared papers)John J.V. McMurray (1 shared paper)Marc Alan Pfeffer (1 shared paper)
- Journals
- New England Journal of Medicine (3 papers)Research and Practice in Thrombosis and Haemostasis (1 paper)Clinical Medicine (1 paper)BMJ Open (1 paper)JAMA Network Open (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Robert A. Fowler
13 papers receiving 3.0k citations
Robert A. Fowler's Hit Papers
Peers
Comparison fields: 5 of 110
- Pharmacology 1.7k
- Biochemistry 300
- Cancer Research 279
- Oncology 439
- Cardiology and Cardiovascular Medicine 360
Countries citing papers authored by Robert A. Fowler
This map shows the geographic impact of Robert A. Fowler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Fowler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Fowler more than expected).
Fields of papers citing papers by Robert A. Fowler
This network shows the impact of papers produced by Robert A. Fowler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Fowler. The network helps show where Robert A. Fowler may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. Fowler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention Hit paper breakdown → | 2005 | 1726 |
| 2 | Celecoxib for the Prevention of Colorectal Adenomatous Polyps Hit paper breakdown → | 2006 | 839 |
| 3 | 2008 | 312 | |
| 4 | 2019 | 87 | |
| 5 | 2010 | 42 | |
| 6 | 1973 | 39 | |
| 7 | 2023 | 36 | |
| 8 | 2015 | 24 | |
| 9 | 2004 | 20 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 6 | |
| 12 | 2017 | 1 | |
| 13 | 2023 | 1 | |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 |
About Robert A. Fowler
Robert A. Fowler is a scholar working on Critical Care and Intensive Care Medicine, Pharmacology, Rheumatology, Modeling and Simulation and Urology, having authored 15 papers that have together received 3.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (3 papers), Infection Control and Ventilation (1 paper), COVID-19 Clinical Research Studies (1 paper), COVID-19 epidemiological studies (1 paper), Liver Disease and Transplantation (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Urinary Bladder and Prostate Research (1 paper) and Cystic Fibrosis Research Advances (1 paper). The work is most often cited by research in Pharmacology (1.7k citations), Biochemistry (300 citations), Cancer Research (279 citations), Oncology (439 citations) and Cardiology and Cardiovascular Medicine (360 citations). Robert A. Fowler has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Scott David Solomon, Janet Turk Wittes, Ann Graham Zauber, Peter V. Finn, Monica M. Bertagnolli, Ernest T. Hawk, John J.V. McMurray, Marc Alan Pfeffer, William F. Anderson and Nadir Arber. Their work appears in journals such as New England Journal of Medicine, Research and Practice in Thrombosis and Haemostasis, Clinical Medicine, BMJ Open and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.